Weiwei Xiao

8PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 19, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.

Wei-Jian Mei, Xiao-Zhong Wang, Xuan Zhang

|Feb 13, 2024
Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after neoadjuvant chemoradiotherapy.

Baoqiu Liu, Huilong Luo, Bin Li

|May 08, 2023
Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.

Shuang Liu, XiaoZhong Wang, YeZhong Zhuang

|Nov 24, 2021
Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.

Yan Yuan, Wei-Hao Xie, Rong-Zhen Li

|Jul 30, 2021
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis.

Chengjing Zhou, Ting Jiang, Rongzhen Li

|Jun 19, 2021
Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer.

Shu Zhang, Rong Zhang, Rong-Zhen Li

Pageof 2

Frequent Collaborators

6 joint publications

Yuanhong Gao

2 joint publications

Hui Chang

1 joint publications

Jibin Li

1 joint publications

Weiwei Xiao